Catalyst Wire Dossier Catalyst Wire Dossier

Lympreva

dasiprotimut-t · Biovest Europe Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lympreva, covering 2015-07-17 to 2015-07-17. Get the full timeline:

Most recent: EMA Refused: Lympreva (dasiprotimut-t) — Biovest Europe Ltd

See pricing